Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Gilead Sciences    GILD

GILEAD SCIENCES (GILD)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Gilead Sciences
Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases

Gilead Sciences, Inc. is a biopharmaceutical company, which discovers, develops and commercializes therapeutics for unmet medical need.

It focuses on human immunodeficiency virus and liver diseases, such as chronic hepatitis C virus infection & chronic hepatitis B virus infection, hematology & oncology, and cardiovascular & inflammation as well as respiratory diseases.

The company's products include Descovy, Odefsey, Genvoya, Stribild, Complera, Atripla, Truvada, Viread, Emtriva, Tybost, Vitekta, Vemlidy, Epclusa, Harvoni, Sovaldi, Viread, Hepsera, Zydelig, Letairis, Ranexa, Lexiscan, Cayston, Tamiflu, AmBisome and Macugen.

Gilead Sciences was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

Number of employees : 9 000 persons.
Sales per Businesses
20152016Delta
USD (in Million)%USD (in Million)%
Innovative Medicines32,639101.9%30,390100.2% -6.89%
Sales per Regions
20152016Delta
USD (in Million)%USD (in Million)%
United States21,23466.3%19,35463.8% -8.85%
Europe7,52823.5%6,36521% -15.45%
Other Countries3,87712.1%2,1447.1% -44.7%
Japan--2,5278.3%-
Managers
NameAgeSinceTitle
John Milligan561990President, Chief Executive Officer & Director
John Martin651990Executive Chairman
Kevin B. Young592016Chief Operating Officer
Robin L. Washington MBA, CPA542008Chief Financial Officer & Executive Vice President
Norbert W. Bischofberger, PhD611990Chief Scientific Officer & Executive VP-Research
Gregg H. Alton511999Executive VP-Corporate & Medical Affairs
Andrew Cheng MD, PhD-1999Executive VP-Clinical Research & Development
William A. Lee, PhD621991Executive Vice President-Research
John G. McHutchison, PhD-2010Executive Vice President-Clinical Research
George Pratt Shultz, PhD941996Director-Emeritus
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 1,305,926,217 1,296,875,958 99.3% 0 0.0% 99.3%
Shareholders
NameEquities%
The Vanguard Group, Inc. 92,841,960 7.11%
BlackRock Fund Advisors 68,920,074 5.28%
SSgA Funds Management, Inc. 58,119,811 4.45%
Parnassus Investments 19,464,445 1.49%
Capital Research & Management Co. (Global Investors) 18,299,758 1.40%
Fidelity Management & Research Co. 17,749,558 1.36%
Northern Trust Investments, Inc. 16,430,476 1.26%
Geode Capital Management LLC 15,093,203 1.16%
T. Rowe Price Associates, Inc. 14,976,091 1.15%
Norges Bank Investment Management 13,923,308 1.07%
Holdings
NameEquities%Valuation
Galapagos (GLPG) 6,760,70113.3%688,873,651 USD
Markets and indexes
- NASDAQ All Markets
- Nasdaq Global Select Market
- Nasdaq 100 / SP100, SP500, Stoxx Americas 100, Stoxx Global 200, Stoxx NorthAmerica 50, Stoxx USA 50
Stock Exchange Codes
- Bloomberg Code :  GILD:US
- Reuters Code :  GILD.O
- Datastream Code :  @GILD
Company contact information
Gilead Sciences
333 Lakeside Drive
US-CA 94404 San Mateo, California
États-Unis (les)

Phone : +1 650 574 3000
Fax : +1 650 578 9264
Internet : http://www.gilead.com
Sector Bio Therapeutic Drugs
1st jan.Capitalization (M$)
GILEAD SCIENCES11.73%104 487
REGENERON PHARMACEUTICALS19.69%47 079
VERTEX PHARMACEUTICALS110.07%39 018
ACTELION23.81%29 869
GENMAB14.75%12 912
EXELIXIS, INC.84.17%8 091
BIOVERATIV INC0.00%6 498
BLUEBIRD BIO INC125.45%6 341
TESARO INC-14.11%6 155
TONGHUA DONGBAO PHARMACEUTICAL CO., LTD.-0.14%5 655
NEUROCRINE BIOSCIENCES, INC.52.35%5 242
JUNO THERAPEUTICS INC130.24%4 810
HUALAN BIOLOGICAL ENGINEERING INC--.--%4 035
CLOVIS ONCOLOGY INC77.22%3 848
PEPTIDREAM INC-42.76%3 745
BEIGENE LTD (ADR)177.44%3 742
BIOCON LTD22.47%3 524
AGIOS PHARMACEUTICALS INC66.76%3 368
SAREPTA THERAPEUTICS INC87.46%3 308
AVEXIS INC112.07%3 231
BEIJING SL PHARMACEUTICAL CO LTD--.--%3 013
Connections : Gilead Sciences
Biotechnology Innovation Organization
The Aids Institute, Inc.
Kite Pharma, Inc.
Gilead Foundation
University of Southern California
Interplast
Collidion, Inc. (California)
InCarda Therapeutics, Inc.
Ohio Wesleyan University
Boys & Girls Club of Oakland
The Royal Australasian College of Physicians
Partners In Health
Children's Discovery Museum
Global Virus Network
CGI Pharmaceuticals, Inc.
Oxford BioTherapeutics Ltd.
UCSF Benioff Children's Hospital Oakland
Acuitus, Inc.
© 2017 People , Fundamentals and Ownership    © 2017 Cofisem